Skip to content

Comparison of the effect of aromatherapy with Jasmine and Clary sage oils on sexual dysfunction

Comparison of aromatherapeutic effect of Jasmine and Clary sage oils on sexual dysfunction of women of reproductive age

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160308026971N13
Enrollment
168
Registered
2022-01-29
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual disorder. Other sexual disorders

Interventions

Intervention 1: First intervention group: 2 drops 2 times a day on the back of the upper lip (under the nose) as an aromatherapy of Clary sage oil 45% with sweet almond oil base for 6 weeks, prepared

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Iranian nationality Monogamy Be in the range of reproductive ages (15 to 45 years) Existence of sexual dysfunction (according to the score obtained from the questionnaire, score less than 28) Having vaginal sex at least once a week

Exclusion criteria

Exclusion criteria: Pregnancy and Breastfeeding Use of any drug that affects a person's sexual response Drug use in couples Existence of known psychological problems or systemic diseases affecting sexual function in the couple according to the individual (cardiovascular disease, diabetes, lower urinary tract symptoms, rheumatoid arthritis, urinary incontinence, anxiety, obsession and depression) Existence of olfactory disturbance and other disorders related to the nose according to the individual Existence of digestive disorders such as nausea, vomiting following inhalation of various odors Existence of obvious and important interpersonal problems between husband and wife, according to the wife History of allergies to the studied oils Existence of obvious vaginal infection according to the person's own statement

Design outcomes

Primary

MeasureTime frame
Sexual dysfunction score. Timepoint: Before the intervention, the end of the intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzeyeh Loripoor

Rafsanjan University of Medical Sciences

marzeyehloripoor@yahoo.com+98 34 3428 0035

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026